Flurbiprofen axetil promotes neuroprotection by activation of cerebral peroxisome proliferator-activated receptor gamma after focal cerebral ischemia in rats

Chinese Medical Journal

Volumn 125, Issue 20, 2012, Pages 3719-3724

  Liu, Jun le ^a,b   Jin, Jian wen ^c   Pei, Shu jun ^a   Wang, Chen ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Cardiology   (China)

Author keywords

Cerebral ischemia; Flurbiprofen axetil; Neurologic deficit score; Neuroprotection; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; FLURBIPROFEN AXETIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM;

ANIMALS; BRAIN ISCHEMIA; CYCLOOXYGENASE INHIBITORS; FLURBIPROFEN; MALE; NEUROPROTECTIVE AGENTS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867909820     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.20.022     Document Type: Article

References (24)

1. Wang N, Guo QL, Ye Z, Xia PP, Wang E, Yuan YJ. Preconditioning of intravenous parecoxib attenuates focal cerebral ischemia/reperfusion injury in rats. Chin Med J 2011; 13: 2004-2008.
2. Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, Lou FC, et al. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J 2009; 17: 1996-2001.
3. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001; 14: 89-94.
4. Wang C, Liu JL, Sang HF, Lü Y, Dong HL, Xiong LZ. Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a rat model of transient focal cerebral ischemia. Chin Med J 2008; 24: 2572-2577.
5. Zuhayra M, Zhao Y, Von Forstner C, Henze E, Gohlke P, Culman J, et al. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat. Neuropathol Appl Neurobiol 2011; 37: 738-752.
6. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-424.
7. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001; 169: 453-459.
8. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, et al. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001; 120: 460-469.
9. Ozawa H, Shioda S, Dohi K, Matsumoto H, Mizushima H, Zhou CJ, et al. Delayed neuronal cell death in the rat hippocampus is mediated by the mitogenactivated protein kinase signal transduction pathway. Neurosci Lett 1999; 262: 57-60.
10. Yue TT, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptorgamma agonist rosiglitazone. Circulation 2001; 104: 2588-2594.
11. Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, et al. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol 2003; 23: 267-276.
12. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005; 130: 685-696.
13. Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D, et al. A peroxisome proliferator-activated receptor gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005; 36: 353-359.
14. Collino M, Patel NS, Lawrence KM, Collin M, Latchman DS, Yaqoob MM, et al. The selective PPAR-γ antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int 2005; 68: 529-536.
15. Dereck K, Sheldrick EL, Wathesb DC, Abayasekara DR, Flint AP. A PPAR-independent pathway to PUFA-induced COX-2 expression. Mol Cell Endocrinol 2008; 287: 65-71.
16. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
17. Sang HF, Li JS, Liu JL, Wang Z, Huo TT, Sun J, et al. Preconditioning with +Gz acceleration (head-to-foot inertial load) produces neuroprotection against transient focal cerebral ischemia in rats. Neurosci Lett 2008; 445: 78-82.
18. Collin M, Abdelrahman M, Thiemermann C. Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock. Eur J Pharmacol 2004; 486: 233-235.
19. Garcia JH, Liu KF, Ye ZR, Gutierrez JA. Incomplete infarction and delayed neuronal death after transient middle cerebral artery occlusion in rats. Stroke 1997; 28: 2303-2310.
20. Michael G, Nicolette CB, David JS, Martin RL, Sarabjit SM, Myra AN. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11: 607-615.
21. Juraj C, Zhao Y, Peter G, Thomas H. PPAR-γ: therapeutic target for ischemic stroke. Trends Pharmacol Sci 2007; 28: 244-249.
22. Zhao Y, Andreas Patzer, Thomas Herdegen, Peter Gohlke, Juraj Culman. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J 2006; 20: 1162-1175.
23. Tomokazu S, Ikuo I, Nobuo A, Asano Y, Sawada M, Furuya D, et al. A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005; 36: 353-359.
24. Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, et al. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway. Neuroscience 2011; 176: 381-339.